Enemeez® Plus

Manufacturer
Quest Products, LLC | Enemeez LLC DBA Summit Pharmaceuticals
Effective date
2026-06-30
Label type
HUMAN OTC DRUG LABEL
Version
23
Source
weekly-update
Hydrated at
2026-07-17 21:41:53

Label at a glance#

ProductENEMEEZ Plus
Active ingredientBENZOCAINE, DOCUSATE SODIUM
Label structure16 sections

Indications and uses

For relief of occasional constipation (irregularity). This product generally produces a stimulus and bowel movement in 2 to 15 minutes.

Dosage and administration

Adults and children 12 years of age and older (with adult supervision) one to three units daily. Children 2 years and over but not more than 12 years should consult a doctor prior to use and not exceed one unit daily (with adult supervision). Twist off and remove tip; Lubricate tip prior to insertion: Place a few drops of water or product on the shaft prior to insertion. Also apply one of these lubricants to the a...

Storage and handling

Other Information Store at room temperature 15°-30° C (59°-86° F)

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (per mini enema)

Docusate Sodium USP 283 mg

Benzocaine 20mg

OTC - PURPOSE SECTION

Docusate Sodium USP 283 mg ............. Stool Softener Laxative

Benzocaine 20mg ................................ Anesthetic

Uses

INDICATIONS & USAGE SECTION

For relief of occasional constipation (irregularity). This product generally produces a stimulus and bowel movement in 2 to 15 minutes.

Warnings

WARNINGS SECTION

For rectal use only. This is not a suppository. Do not take orally. Individuals with sensitivity to Benzocaine should not use this product.

Ask a doctor before use if you have:

OTC - ASK DOCTOR SECTION

  • abdominal pain, nausea or vomiting.
  • a sudden change in bowel habits that persists over a period of 2 weeks.

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are presently taking mineral oil.

Stop use and ask a doctor if you:

OTC - STOP USE SECTION

  • have rectal bleeding.
  • failed to have a bowel movement after use. This may indicate a serious condition.
  • encounter resistance. Forcing the tube may result in injury or damage to the rectum. If product is not administered properly and occasional rectal examinations are not performed, serious complications can arise. Occasional rectal exams are imperative for patients with impaired rectal function, especially loss of sensation.
  • require a bowel program for longer than 1 week.
  • experience rectal irritation or a rash around the anus appears.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OVERDOSAGE SECTION

In case of accidental ingestion or overdose, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years of age and older (with adult supervision) one to three units daily. Children 2 years and over but not more than 12 years should consult a doctor prior to use and not exceed one unit daily (with adult supervision).

Twist off and remove tip; Lubricate tip prior to insertion: Place a few drops of water or product on the shaft prior to insertion. Also apply one of these lubricants to the anus before inserting the enema. With steady pressure, gently insert the tube into the rectum with care to prevent damage to the rectal wall. Squeeze to empty the contents. Continue squeezing the tube until it is removed from the rectum. Remove the disposable tube and discard. A small amount of liquid may remain in the tube after use.

Positioning:
For best results, lay on the left side with knees bent.

Alternate Positions:

  • Administer while seated on the toilet.
  • Kneel with the left arm folded comfortably, then lower head and chest forward until side of face is resting on the surface.

Other Information

STORAGE AND HANDLING SECTION

Other Information Store at room temperature 15°-30° C (59°-86° F)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Inactive Ingredients Polyethylene Glycol and Glycerin USP

OTC - QUESTIONS SECTION

Questions or Comments: 1-888-273-9734 or www.enemeez.com

SPL UNCLASSIFIED SECTION

Manufactured by:
Enemeez, Inc., Phoenix, AZ 85050

Distributed by:
Alliance Labs, L.L.C
2515 E. Rose Garden Lane, Suite #1
Phoenix, AZ 85050

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

9877-59877-5

30count30count

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
17433-9877-0ML - Milliliter17433-98772e9b0ac6-919d-4fe2-a8ba-a2b8c95ed35112018-05-09
17433-9877-2ML - Milliliter17433-98770f3c3df0-f564-4e9a-9b9e-7083e97ea8fe12025-09-12
17433-9877-3ML - Milliliter17433-987753354c2d-cba7-4902-8a17-9cd8f7ede81b12013-02-13
17433-9877-5ML - Milliliter17433-98777b0c7f3e-bcf2-4dd1-b6d2-bb54d55b020912022-05-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BENZOCAINEACTIVE INGREDIENTU3RSY48JW53
DOCUSATE SODIUMACTIVE INGREDIENTF05Q2T2JA03
BENZOCAINEACTIVE MOIETYU3RSY48JW53
DOCUSATEACTIVE MOIETYM7P27195AG3
GLYCERININACTIVE INGREDIENTPDC6A3C0OX3
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1A3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
222026-03-25full-release2026-06-01 01:51:31

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 27 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / ORAL2400 mgExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii+route
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXLIQUID / TOPICAL2.5 %w/wExact identifier — unii+dosage form
27 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ENEMEEZ PlusDOCUSATE SODIUM AND BENZOCAINEQuest Products, LLC1670ca59-7275-4ac6-bef4-674a7b24c7b32026-06-30WarningsExact identifier
ndc (package): 17433-9877-5
ndc (package): 17433-9877-7
ndc (package): 17433-9877-3
ndc (package): 17433-9877-4
ndc (package): 17433-9877-0
ndc (package): 17433-9877-6
ndc (package): 17433-9877-2
ndc (package): 17433-9877-1
ndc (product): 17433-9877
ndc11 (package): 17433987701
ndc11 (package): 17433987704
ndc11 (package): 17433987702
ndc11 (package): 17433987705
ndc11 (package): 17433987700
ndc11 (package): 17433987706
ndc11 (package): 17433987703
ndc11 (package): 17433987707
spl id: 557c260c-c8fb-da2f-e063-6294a90a5501
spl set id: 1670ca59-7275-4ac6-bef4-674a7b24c7b3

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.